O utbreaks of malaria in southern Algeria have been observed for many years, including a major epidemic in Dajnet in 1928-1929 (1) . Most (>90%) documented cases were attributed to Plasmodium falciparum (2) ; Anopheles sergenti and An. multicolor mosquitoes were incriminated as potential vectors (3) . The Sahara Desert has been regarded as an effective barrier against northward expansion of An. gambiae mosquitoes, the main malaria vector in Africa, into Algeria. However, this mosquito has been detected near the Algeria-Mali border (4) .
In recent years, marked changes in the environment and the economy of southern Algeria have occurred (exploitation of underground water resources, growth of the human population in several oases, and development of a transport infrastructure). The new Trans-Saharan Highway, which links Algeria and West Africa, is a potential route for introduction of tropical vectors and parasites into southern Algeria (2, 5) .
In November 2007, a total of 26 autochthonous cases of P. falciparum malaria were detected in Tinzaouatine, a village in Algeria near the Algeria-Mali border. We present results of a parasitologic and entomologic study conducted during the outbreak and discuss the potential for establishment of vectors and P. falciparum malaria in Algeria.
The Study
Tinzaouatine (altitude 620 m, 19.95°N, 2.96°E, population ≈12,000) is a village near the Mali border, ≈2,000 km south of Algiers and 578 km southeast of Tamanrasset. Most of its inhabitants are nomadic Tuareg. The climate is arid (annual mean temperature 27°C, range 17°C-33°C, <100 mm rain/year; Offi ce Nationale de Météorolo-gie, Algiers, Algeria). Precipitation is associated with the West African monsoon and restricted to a short period (June-September). The Tinzaouatine River, which is dry for most of the year, occasionally fl oods. After fl ooding, receding water results in abundant pools (gueltas) that are ideal breeding sites for anopheline mosquitoes. Livestock (mostly sheep and goats) are common in the region. However, no agricultural activity takes place and no irrigation system exists.
During a 2-week period in December 2007, adult mosquitoes were collected by morning indoor spraying in 4 houses and 3 nomad tents (2×/week), human landing catches (2 nights/week), and CDC light traps and mouth aspirators in resting sites (at night). Adult sampling was conducted in dwellings of persons with cases of malaria. Human landing catches were made on 2 adult volunteers from the medical research team from 8:00 PM to 6:00 AM. Larvae and pupae were collected by dipping into 2 mosquito-positive pools (1× over a 3-hour period). Adult mosquitoes derived from pupae were identifi ed by using morphologic keys (6) and genotyped by rDNA PCR to determine species within the An. gambiae complex (7).
Eleven pools were tested for anopheline larvae. However, many had been treated with insecticide. Larvae of anophelines and other species were collected from 2 gueltas (area 30 m 2 and 200 m 2 , respectively). A total of 123 anopheline larvae were reared into adults (35 males and 12 females hatched). All specimens were of the Mopti (M) molecular form of An. gambiae sensu stricto mosquitoes. Use of entomologic controls at the same site in 2008 confi rmed that the unique anopheline species present in this area was An. gambiae sensu lato. No adult mosquitoes were captured, probably because of insecticide spraying during the period of sampling to control the outbreak and because of a temperature <10°C at night.
Clinical diagnosis of malaria was made at the health center in the village. A total of 1,468 samples were examined by microscopy during the outbreak. Twenty-six patients (11 female and 15 male, age range 1-43 years) who had fever, chills, and rigor had samples positive for P. falciparum. None of these patients had traveled outside Tinzaouatine before the outbreak, which indicated that these cases were autochthonous. All patients were treated with chloroquine (10 mg/kg/ day for 2 days and 5 mg/kg for 3 days). Clinical resistance to chloroquine was not reported and no deaths occurred. Informed consent was obtained from each patient or adult guardian of children enrolled in this study at the time of blood collection.
Ten samples were chosen for molecular study; 8 were from patients positive by microscopy and 2 were from patients with malaria symptoms negative for P. falciparum by microscopy. Samples were processed by placing a drop of blood on fi lter paper. Molecular analysis was conducted according to the protocol described by Snounou et al. (8) . Molecular screening by real-time PCR was used to detect mutations in the P. falciparum dihydrofolate reductase (dhfr), dihydropteroate synthase (dhps), and chloroquine resistance transporter (crt) genes, which are involved in P. falciparum drug resistance (9) . Molecular analysis results of 5 PCR-positive blood samples showed the pfcrt 76T and the dhfr 108N mutations, and 4 showed the quadruple mutation (dhfr 51I, 59R, 108N and dhps 436A). No mutations were detected in the dhps 540 codon. We also identifi ed a P. falciparum isolate with a unique sextuple drug resistance profi le (Y 86mdr1 /T 76crt /I 51dhfr /R 59dhfr /N 108dhfr /A 436dhps ).
Although all patients were treated with chloroquine and despite our evidence of polymorphisms in genes linked to chloroqunie resistance, no clinical failures were observed. Polymorphisms in the crt gene are strongly associated with chloroquine resistance. Involvement of the mdr1 gene in chloroquine resistance has been challenged, but variation at codon 86 of this gene modulates resistance to chloroquine (10) .
Conclusions
An average of 300 cases of malaria is recorded in cities in southern Algeria every year, mostly in Tamanrasset and Adrar. Parasites are introduced by infected humans; >90% of cases originate in Mali and Niger (11) . Several autochthonous infections have been reported in Tinzaouatine (Table). We suggest that introduction of malaria into this area likely refl ects the highly mobile nature of local populations and associated travel to or from areas endemic for malaria. Interethnic confl icts in northern Mali have also increased the displacement of populations toward Algeria.
An. gambiae mosquitoes in Algeria probably originated in Mali. Algeria has borders with Mali and Niger, countries where An. gambiae sensu lato mosquitoes are present (4). The most likely mode of introduction of An. gambiae mosquitoes into Algeria is passive transport by vehicles and trucks because considerable traffi c moves across its borders (12) . An alternative hypothesis is that mosquitoes were carried by wind from breeding sites in southern Mali, a mode of dispersal that has been described for other species of mosquitoes (13) .
An. gambiae mosquitoes found in Algeria were of the M molecular form. Current knowledge of genetics and distribution of An. gambiae sensu lato mosquitoes (14, 15) suggests that this species is probably of the chromosomal M form, which is adapted to an arid climate. Unfortunately, chromosomal inversions in mosquitoes found in Algeria could not be assessed because of lack females at the halfgravid stage (during blood digestion and egg development). However, conditions in 2007 were probably favorable for establishment of this species because the infested area had experienced unusual heavy rainfall, particularly in November (Figure) . Moreover, the location of this species ranges from the Sahel in West Africa to rain forests in equatorial regions (14) .
We cannot predict whether this highly effective vector will become established in southern Algeria, with an accompanying risk for establishment of malaria, or whether this region will be a source of vectors and parasites that could threaten the rest of Algeria. The bionomics of this species and its ability to survive the long hot and dry season are among several factors that need to be investigated. Mr Boubidi is a medical and veterinary entomologist in the Laboratory for Parasitic Epidemiology at the Institut Pasteur of Algeria. His research interests include systematic, bionomic, and vectorial capacities of mosquitoes and sand fl ies for estimating exposure and infectious risks.
